NASDAQ, ANGO - Angiodynamics Inc

We are a provider of innovative medical devices used in minimally invasive,  image-guided procedures to treat peripheral vascular disease, or PVD, and local  oncology therapy options for treating cancer, including radiofrequency ablation,  or RFA, and systems and embolization products for treating cancerous tumors. We  design, develop, manufacture and market a broad line of therapeutic and  diagnostic devices that enable interventional physicians (interventional  radiologists, vascular surgeons, surgical oncologists and others) to treat PVD,  tumors, and other non-coronary diseases. Unlike several of our competitors that  focus on the treatment of coronary diseases, we believe that we are the only  company whose primary focus is to offer a comprehensive product line for the  interventional treatment of these diseases.  We have been in business since 1988. Our corporate headquarters is located at  603 Queensbury Avenue, Queensbury, New York 12804.  ...

Sector:	Health Care
Industry:	Medical/Dental Instruments
P/E Ratio:	N/A
PEG Ratio:	1.86
EPS:	N/A
DivYield:	N/A
PtB:	2.1115
PtS:	1.81
EBITDA:	47.67M
Shares:	40.61M
Market Cap:	345.57M
52wk range:	5.83 - 13.50

216.73.216.229
United States